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with cardiovascular manifestations in SLE, especially in Indian
subjects.
Aims and methods: The study aimed to characterize the cardio-
vascular manifestations of SLE and correlate them with anti-
dsDNA and APLA positivity. Anti-ds DNA was assayed by immu-
noﬂourescence staining on Hep-2 cells and APLAwasmeasured by
both liquid phase (lupus anticoagulant) ELISA and solid phase (anti
cardiolipin) ELISA assays.
Results: All the study subjects (n = 30) were females with a mean
age of 23.07 years. Themost frequent CVmanifestation was that of
pericardial involvement occurring in 63.3% (n = 19) patients. Valve
thickening or regurgitation (46.6%), myocarditis (13.3%) and pul-
monary artery hypertension (20%) were the other major CV invol-
vements in SLE. Serological assay revealed 83.3% (n = 25) positivity
for anti-ds DNA, while APLA was positive in 36.7% (n = 11) of the
patients. APLA was found to be signiﬁcantly associated with valv-
ular heart disease ( p = 0.0295). APLA also had signiﬁcant associa-
tionswith increased pulmonary artery systolic pressure ( p < 0.001)
andmyocarditis ( p = 0.005). Anti ds DNAwas not found to have any
signiﬁcant association with either valvular heart disease
( p = 0.102), myocarditis or pulmonary artery hypertension but
was signiﬁcantly associated with pericarditis ( p = 0.028).
Conclusions: As observed in western series, APLA were signiﬁ-
cantly associated with valvular heart disease in SLE in our series;
although in contrast, pericarditis was more prevalent in anti
dsDNA positive than negative patients. This study results could
prompt early echocardiographic examinations in patientswith SLE
and APLA positivity, and invite larger studies to establish patho-
genic role of these antibodies.
QT dispersion in Type 1 and Type 2
diabetes mellitus
V.K. Joglekar
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Background: Increased QT dispersion (QTd) occurs in some cases
of Diabetes Mellitus (DM) which may increase the risk of serious
ventricular arrhythmia and sudden death. Type 1 DM and Type 2
DMmay differ in incidence of increased QTd. Similarly, there may
be difference in number of patients with increased QTd in con-
trolled and uncontrolled DM in each group.
Methods: 100 cases, each of Type 1 and Type 2 DM and each group
having 50 controlled and 50 uncontrolled cases along with 50 age
and sex matched healthy volunteers comprised material of this
study. In both these groups of Type 1 and Type 2 DM, age, sex and
duration of DM were properly matched. Detailed clinical examina-
tion (with special attention to postural hypotension and resting
tachycardia), relevant biochemical investigations including fasting
and postprandial glucose, HbA1c and ECGs were done in all cases.
In ECG, QTd was meticulously calculated as per guidelines. The
patients with uncontrolled blood glucose and increased HbA1c
were given appropriate treatment. HbA1c was repeated 90 days
after normalization of blood glucose and QTd was again analyzed.
Results:QTdwas increased in 16 cases of Type 1 DM (controlled – 7,
uncontrolled – 9) whereas in 18 cases of Type 2 DM (controlled – 7,
uncontrolled – 11). Postural hypotension and resting tachycardia
were observed in 8 cases of Type 1 DM and 10 cases of Type 2 DM.
After control of blood glucose and HbA1c, ECGs were repeated and
QTd was analyzed. In Type 1 DM, 1 patient from uncontrolled
group and in Type 2 DM, 2 patients from uncontrolled group, after
control of blood glucose and HbA1c showed normalization of QTd.
Conclusions: In the present study, QTdwas increased in both Type
1 DM and Type 2 DM group but in relatively more number of
patients in Type 2 DM group. After control of blood glucose and
HbA1c, 1 patient from Type 1 DM group and 2 patients Type 2 DM
group showed normalization of QTd and this difference was very
slight. This slight difference may be related to higher age of
patients and age related changes in myocardium in Type 2 DM
group. Increase in QTd may be related to cardiac dysautonomia or
due to structural changes in myocardium. Patients with increased
QTd require more attention as it may lead to serious ventricular
arrhythmia and sudden death. However, more studies on large
number of patients are required to conﬁrm these observations and
ﬁnd out their mechanism.
QT dispersion in acute stroke
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Background: ECG changes are known in acute stroke and increased
QT dispersion (QTd) is one of them. Increased QTd is associated
with serious ventricular arrhythmia and sudden death.
Methods: 100 cases of acute stroke and 50 age and sex matched
healthy volunteers comprisedmaterial of this study. All caseswere
evaluated within 24 hours of onset of acute stroke. In addition to
neurological assessment, CT/MRI and ECG changes were analyzed.
In 30 out of 100 patients, ECGs were done within 10 hours whereas
in remaining 70 cases, ECGswere done between 10 to 20 hours after
onset of acute stroke as they came late for admission in the
hospital.
Results: These stroke patients had weakness either on one side of
body or in one of the limbs i.e. monoparasis/plegia. 3 patients were
unconscious. CT/MRI revealed lesions in cerebral cortex or brain
stem in the formof hemorrhage, thrombosis or embolism. In 30 out
of 100 patients, ECGs were done within 10 hours whereas in
remaining 70 cases, ECGs were possible only after 10 hours as they
came late for admission in the hospital. QTd was increased in 16
cases out of 70 in which ECGs were done after 10 hours of onset of
stroke. In this group, 13 cases hadmassive stroke (massive hemor-
rhage – 10, massive infarction – 3) which included 3 unconscious
patients mentioned above. In addition, 3 out of 50 healthy volun-
teers also showed increased QTd.
Conclusions: Increased QTdwas observed in 16 cases (including 13
cases of massive stoke) of acute stroke. In all these cases, ECGs
were done after 10 hours of onset of acute stroke. It appears that
early ECG may not be rewarding as increase in QTd occurs little
late. In contrast, only 3 out of 50 healthy volunteers showed
increased QTd. Sudden death in acute stroke may occur due to
increased QTd (and occurrence of serious ventricular arrhythmia)
or due to damage of vital centres in brain. It appears that patients
with increased QTd in stroke may require more medical attention.
If patients of acute stroke with increased QTd are meticulously
monitored, sudden death may be prevented. However, more stu-
dies on large number of cases are required to conﬁrm these
observations and ﬁnd out their mechanism.
Ivabradine versus metoprolol in
patients with acute inferior wall
myocardial infarction – 'Expanding
arena for ivabradine'
Kumari Priti
Background: Beta-blockers in ST-segment elevation myocardial
infarction (STEMI) are particularly indicated in patients with high
heart rates (HR) or LV dysfunction. But AV blocks are biggest
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concern in inferior MI with beta-blockers. In contrast ivabradine
lowers heart rate with a lesser risk of AV blocks.
Aim: To investigate the feasibility, tolerability, and the efﬁcacy of
ivabradine versusmetoprolol in acute inferior STEMI and during 30
days of follow-up.
Methods: It's a prospective double blind single centre randomized
controlled study. Of 1032 patients with acute inferior STEMI, 564
patients did not fulﬁll the inclusion criteria andwere excluded. 468
patients were included in the study and were randomized in 1:1
manner to ivabradine (group A) and metoprolol (group B). 42
patients were lost on follow up and excluded. Per protocol analysis
of 426 patients (group A – 210 and group B – 216) was done. The
primary end point was 30-day incidence of MACE including death,
nonfatal MI, complete heart block (CHB) and heart failure. Second-
ary endpoints included 30 day incidence of recurrent angina, read-
mission, ﬁrst or second degree AV block and tachyarrhythmias.
Results: Both the drugs decreased themean heart rate 62.22  2.95
(group A) vs 62.53  3.59 (group B) beats per minute ( p = 0.33).
Ejection fraction improved in both the groups. The two groups
did not differ signiﬁcantly in their primary endpoints in terms of
death (group A = 1.90% vs group B = 1.85%, OR = 1.03, 95% CI = 0.25–
4.17, p = 0.97), reinfarction (group A = 0.95% vs group B = 0.93%,
OR = 1.03, 95% CI = 0.14–7.37, p = 0.98), heart failure (group
A = 4.76% vs group B = 2.78%, OR = 1.75, 95% CI = 0.62–4.90,
p = 0.29) or CHB (0% vs 2.78%, OR = 0.08, 95% CI = 0.004–1.37
p = 0.08). There were no signiﬁcant differences in the secondary
end points of recurrent angina, readmission and NSVT but sig-
niﬁcantly more ﬁrst degree AV blocks occurred with metoprolol
(13.89% vs 2.86%, OR = 5.48, 95% CI = 2.23–13.47, p = 0.0002).
Conclusions: Ivabradine is equally effective as metoprolol in acute
inferior wall STEMI patients for lowering the heart rate with less
risk of CHB.
Clinical risk factors and angiographic
profile of coronary slow flow in North
Indian population
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Background: ‘‘Coronary slow ﬂow’’ (CSF) is delayed vessel opaci-
ﬁcation in the absence of epicardial stenosis and is characterized
by decreased coronary ﬂow velocity. Studies in different ethnic
groups have found variable risk factors associatedwith CSF. Aim of
present study was to analyse the risk factors and angiographic
proﬁle of CSF in North Indian population which has not been
studied till date.
Methods: 30 patients with CSF and 30 age and sex matched con-
trols without CSF have been studied till date (study is ongoing).
Coronary ﬂow patterns were determined quantitatively by throm-
bolysis in myocardial infarction (TIMI) frame count method. CSF
was deﬁned as TIMI frame count more >27 frames at frame rate of
30 frames per second. Various clinical risk factors (age, sex, dia-
betes, hypertension, dyslipidemia, smoking), hematological and
biochemical parameters (hemoglobin, hematocrit, platelet count,
erythrocyte sedimentation rate (ESR), blood urea, serum creati-
nine, uric acid, homocysteine, ﬁbrinogen, high sensitivity C reac-
tive protein (hsCRP), HbA1C were compared between the two
groups.
Results: Of the 30 patients with CSF, 28 (93%) were males. While 15
patients (50%) presented with chronic stable angina, rest 15 (50%)
presented with acute coronary syndrome. [10 (33%) with unstable
angina and 5 (17%) with non ST elevation myocardial infarction
(NSTEMI)]. 9 patients had CSF in all 3 vessels (30%), 17 had CSF in 2
vessels (57%) and 4 had CSF in 1 vessel (13%). The most common
artery involved was left anterior descending (LAD) [n = 27 (90%)],
followed by left circumﬂex (LCX) [n = 23 (77%)] and right coronary
artery (RCA) [n = 13 (43%)]. Patients with CSF had signiﬁcantly
elevated ESR (16.50  15.75 vs. 6.13  4.72 mm/hr, p = 0.001), ﬁbri-
nogen (393.77  130.87 vs. 307.93  168.44, p = 0.03) and serum
creatinine (393.77  130.87 vs. 307.93  168.44, p = 0.03). No signiﬁ-
cant differences in other risk factors were observed.
Conclusion: This is the ﬁrst study to analyse clinical presentation,
risk factors and angiographic proﬁle associated with CSF in North
Indian population. In this study we found CSF was signiﬁcantly
associated with male sex, raised ESR, elevated ﬁbrinogen and
creatinine.
Feasibility and safety of PCI after
successful thrombolization in acute MI
patients
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3/5 Laxmi Nagar, Cananda Cornar, Patil Lane No 1, Nashik,
Maharashtra, India
Background: Primary percutaneous coronary intervention (PPCI) is
the reperfusion therapy of choice among patients with STEMI
owing to a low risk of reinfarction and improved survival rates.
Thrombolysis is important as ‘‘the appropriate and timely use of
reperfusion therapy is likely to be more important than the choice
of therapy’’. Primary Percutaneous Coronary Intervention after
thrombolysis to achieve TIMI 3/2 ﬂow in the affected epicardial
vessel is a prerequisite for optimal myocardial reperfusion. Pri-
mary PCI is recognized as the best strategy for treatment of
patients for whom it is applicable.
Method: 150 patients were screened and 140 underwent diagnostic
angiography within 24 hours after thrombolysis. Full dose of
thrombolizing agent were used for acute STEMI patients if PCI
was delayed to ≥30 min. Patients were recommended to undergo
diagnostic angiography within 3–24 h after thrombolysis. Patient
with residual stenosis ≥70% in the infarct related artery underwent
PCI. Epicardial arterial ﬂow was assessed using TIMI ﬂow grade.
Result:Out of 150 Patients, 72wereAcute IWMI, 78were AWMI. Out
of 140 patients, 100 patients underwent PCI, 17 patients were
medically managed, and 23 patients underwent CABG. Out of
100 Plasty, 78 had single vessel and 22 had double vessel disease.
TIMI ﬂow before and after PCI (n = 100).
The composite end point of death cardiogenic shock occurred in 2
patients. No TIMI major bleeding & stroke occurred. No patient
needed emergency CABG.
Conclusion: These results support the routine implementation of
an early invasive strategy after successful thrombolization in this
population, with a trend towards a further reduction of reinfarc-
tion and death/reinfarction in higher risk STEMI patients. Use of
thrombolizing agent is still an important option for reperfusion in
many.
n TIMI ﬂow (Before PCI) n TIMI ﬂow (After PCI)
4 TIMI 0 2 TIMI 0
10 TIMI 1 4 TIMI 1
25 TIMI 2 4 TIMI 2
61 TIMI 3 90 TIMI 3
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